| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 2.20e-07 | 4 | 77 | 3 | GO:0001010 | |
| GeneOntologyMolecularFunction | keratan sulfotransferase activity | 8.76e-05 | 4 | 77 | 2 | GO:0045130 | |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 8.76e-05 | 4 | 77 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | dolichyl-diphosphooligosaccharide-protein glycotransferase activity | 1.46e-04 | 5 | 77 | 2 | GO:0004579 | |
| GeneOntologyMolecularFunction | oligosaccharyl transferase activity | 1.46e-04 | 5 | 77 | 2 | GO:0004576 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 2.08e-04 | 30 | 77 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | IgE receptor activity | 2.18e-04 | 6 | 77 | 2 | GO:0019767 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.29e-04 | 31 | 77 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine 6-O-sulfotransferase activity | 3.04e-04 | 7 | 77 | 2 | GO:0001517 | |
| GeneOntologyMolecularFunction | IgE binding | 3.04e-04 | 7 | 77 | 2 | GO:0019863 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 3.04e-04 | 7 | 77 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | IgG binding | 7.89e-04 | 11 | 77 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 1.30e-03 | 14 | 77 | 2 | GO:0019763 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.85e-03 | 227 | 77 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | lamin binding | 2.41e-03 | 19 | 77 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | actin binding | 2.48e-03 | 479 | 77 | 7 | GO:0003779 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF6 ARHGEF10 LMO7 PLEKHG3 SYNE1 PPP1R9A SSH2 TOR1AIP1 POF1B IQGAP3 CNN1 | 3.17e-03 | 1099 | 77 | 11 | GO:0008092 |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 2.00e-07 | 4 | 77 | 3 | GO:0042664 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 4.98e-07 | 5 | 77 | 3 | GO:0042663 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 9.92e-07 | 6 | 77 | 3 | GO:1903225 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 2.76e-06 | 8 | 77 | 3 | GO:0009996 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 5.89e-06 | 10 | 77 | 3 | GO:1903224 | |
| GeneOntologyBiologicalProcess | cell fate specification | 6.67e-06 | 123 | 77 | 6 | GO:0001708 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 8.08e-06 | 11 | 77 | 3 | GO:0001714 | |
| GeneOntologyBiologicalProcess | perforin production | 1.38e-05 | 2 | 77 | 2 | GO:0035944 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 2.20e-05 | 15 | 77 | 3 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 2.20e-05 | 15 | 77 | 3 | GO:0043696 | |
| GeneOntologyBiologicalProcess | positive regulation of mitotic cell cycle | 2.50e-05 | 155 | 77 | 6 | GO:0045931 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 3.28e-05 | 17 | 77 | 3 | GO:0010454 | |
| GeneOntologyBiologicalProcess | stem cell division | 3.35e-05 | 49 | 77 | 4 | GO:0017145 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 3.77e-05 | 338 | 77 | 8 | GO:0045165 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 3.92e-05 | 18 | 77 | 3 | GO:0001711 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 3.92e-05 | 18 | 77 | 3 | GO:2000035 | |
| GeneOntologyBiologicalProcess | co-translational protein modification | 4.12e-05 | 3 | 77 | 2 | GO:0043686 | |
| GeneOntologyBiologicalProcess | dendritic cell antigen processing and presentation | 6.34e-05 | 21 | 77 | 3 | GO:0002468 | |
| GeneOntologyBiologicalProcess | positive regulation of dopaminergic neuron differentiation | 8.21e-05 | 4 | 77 | 2 | GO:1904340 | |
| GeneOntologyBiologicalProcess | nuclear protein quality control by the ubiquitin-proteasome system | 8.21e-05 | 4 | 77 | 2 | GO:0071630 | |
| GeneOntologyBiologicalProcess | mesodermal cell fate commitment | 8.40e-05 | 23 | 77 | 3 | GO:0001710 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CUL3 NANOGP8 NANOGP1 ARHGEF10 NANOG DYNLT3 CEP126 FOXA1 MBD4 CNTROB IQGAP3 DYNC1H1 EDNRA | 8.92e-05 | 1014 | 77 | 13 | GO:0000278 |
| GeneOntologyBiologicalProcess | regulation of cell division | 1.06e-04 | 201 | 77 | 6 | GO:0051302 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 1.38e-04 | 407 | 77 | 8 | GO:0045787 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 1.70e-04 | 29 | 77 | 3 | GO:0042659 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 2.29e-04 | 80 | 77 | 4 | GO:0030514 | |
| GeneOntologyBiologicalProcess | response to lipid | NANOGP8 NANOGP1 UBR5 FCGR3A FCGR3B NANOG CD68 PAPPA TAB2 FOXA1 MBD4 CTSH EDNRA | 2.52e-04 | 1126 | 77 | 13 | GO:0033993 |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 2.52e-04 | 33 | 77 | 3 | GO:2000737 | |
| GeneOntologyBiologicalProcess | cell division | CUL3 NANOGP8 NANOGP1 NANOG TLE6 DYNLT3 BIRC6 CNTROB IQGAP3 DYNC1H1 | 2.59e-04 | 697 | 77 | 10 | GO:0051301 |
| GeneOntologyBiologicalProcess | Fc receptor-mediated immune complex endocytosis | 2.85e-04 | 7 | 77 | 2 | GO:0160006 | |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 3.00e-04 | 35 | 77 | 3 | GO:0048333 | |
| GeneOntologyBiologicalProcess | endoderm development | 3.30e-04 | 88 | 77 | 4 | GO:0007492 | |
| GeneOntologyBiologicalProcess | cell fate commitment involved in formation of primary germ layer | 3.55e-04 | 37 | 77 | 3 | GO:0060795 | |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 3.84e-04 | 38 | 77 | 3 | GO:0035987 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | CUL3 NANOGP8 NANOGP1 CD244 FCGR3A SYNE1 NANOG NTRK3 LAMC2 BIRC6 CTSH IQGAP3 EDNRA | 4.28e-04 | 1190 | 77 | 13 | GO:0008284 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | TGM3 NANOGP8 NANOGP1 NANOG PLXND1 FOXA1 FOXA2 CTSH EDNRA FOXL1 | 4.62e-04 | 750 | 77 | 10 | GO:0048729 |
| GeneOntologyBiologicalProcess | epithelial tube branching involved in lung morphogenesis | 4.81e-04 | 41 | 77 | 3 | GO:0060441 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 5.17e-04 | 42 | 77 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | neuron fate specification | 5.17e-04 | 42 | 77 | 3 | GO:0048665 | |
| GeneOntologyBiologicalProcess | actin filament organization | 6.16e-04 | 509 | 77 | 8 | GO:0007015 | |
| GeneOntologyBiologicalProcess | positive regulation of smoothened signaling pathway | 6.34e-04 | 45 | 77 | 3 | GO:0045880 | |
| GeneOntologyBiologicalProcess | regulation of smoothened signaling pathway | 6.45e-04 | 105 | 77 | 4 | GO:0008589 | |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 6.93e-04 | 107 | 77 | 4 | GO:0009953 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion mediated by cadherin | 7.40e-04 | 11 | 77 | 2 | GO:2000049 | |
| GeneOntologyBiologicalProcess | dichotomous subdivision of an epithelial terminal unit | 7.40e-04 | 11 | 77 | 2 | GO:0060600 | |
| GeneOntologyBiologicalProcess | endoderm formation | 8.15e-04 | 49 | 77 | 3 | GO:0001706 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 8.55e-04 | 197 | 77 | 5 | GO:0030509 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 8.75e-04 | 198 | 77 | 5 | GO:0048754 | |
| GeneOntologyBiologicalProcess | regulation of dopaminergic neuron differentiation | 8.86e-04 | 12 | 77 | 2 | GO:1904338 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell proliferation | 8.86e-04 | 12 | 77 | 2 | GO:0032819 | |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 1.02e-03 | 53 | 77 | 3 | GO:0010453 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 1.04e-03 | 13 | 77 | 2 | GO:0001788 | |
| GeneOntologyBiologicalProcess | pharyngeal arch artery morphogenesis | 1.04e-03 | 13 | 77 | 2 | GO:0061626 | |
| GeneOntologyBiologicalProcess | gastrulation | 1.19e-03 | 212 | 77 | 5 | GO:0007369 | |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 1.20e-03 | 124 | 77 | 4 | GO:0001704 | |
| GeneOntologyBiologicalProcess | protein destabilization | 1.20e-03 | 56 | 77 | 3 | GO:0031648 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell proliferation | 1.22e-03 | 14 | 77 | 2 | GO:0032817 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.26e-03 | 215 | 77 | 5 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.26e-03 | 215 | 77 | 5 | GO:0071773 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 1.40e-03 | 15 | 77 | 2 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 1.40e-03 | 15 | 77 | 2 | GO:0002445 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 1.47e-03 | 131 | 77 | 4 | GO:0032526 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.47e-03 | 131 | 77 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | keratan sulfate biosynthetic process | 1.60e-03 | 16 | 77 | 2 | GO:0018146 | |
| GeneOntologyCellularComponent | Fc-gamma receptor III complex | 8.00e-05 | 4 | 77 | 2 | GO:0033001 | |
| MousePheno | absent primitive endoderm | 5.96e-08 | 9 | 67 | 4 | MP:0011185 | |
| MousePheno | abnormal primitive endoderm morphology | 8.61e-08 | 24 | 67 | 5 | MP:0011183 | |
| MousePheno | abnormal extraembryonic ectoderm morphology | 1.38e-05 | 31 | 67 | 4 | MP:0010736 | |
| MousePheno | disorganized extraembryonic tissue | 2.26e-05 | 35 | 67 | 4 | MP:0002582 | |
| MousePheno | absent extraembryonic ectoderm | 4.60e-05 | 15 | 67 | 3 | MP:0002583 | |
| MousePheno | absent embryonic epiblast | 5.64e-05 | 16 | 67 | 3 | MP:0011184 | |
| MousePheno | abnormal bilaminar embryonic disk morphology | 1.26e-04 | 102 | 67 | 5 | MP:0012103 | |
| MousePheno | abnormal embryonic tissue cell apoptosis | 2.18e-04 | 180 | 67 | 6 | MP:0013503 | |
| Domain | Fork-head_N | 6.48e-08 | 3 | 76 | 3 | IPR013638 | |
| Domain | Forkhead_N | 6.48e-08 | 3 | 76 | 3 | PF08430 | |
| Domain | HNF_C | 6.48e-08 | 3 | 76 | 3 | PF09354 | |
| Domain | Forkhead_box_C | 6.48e-08 | 3 | 76 | 3 | IPR018533 | |
| Domain | STT3 | 1.63e-05 | 2 | 76 | 2 | PF02516 | |
| Domain | Oligo_trans_STT3 | 1.63e-05 | 2 | 76 | 2 | IPR003674 | |
| Domain | TF_fork_head_CS_2 | 3.63e-05 | 46 | 76 | 4 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 3.95e-05 | 47 | 76 | 4 | IPR018122 | |
| Domain | FH | 4.67e-05 | 49 | 76 | 4 | SM00339 | |
| Domain | FORK_HEAD_1 | 4.67e-05 | 49 | 76 | 4 | PS00657 | |
| Domain | FORK_HEAD_2 | 4.67e-05 | 49 | 76 | 4 | PS00658 | |
| Domain | Fork_head_dom | 4.67e-05 | 49 | 76 | 4 | IPR001766 | |
| Domain | FORK_HEAD_3 | 4.67e-05 | 49 | 76 | 4 | PS50039 | |
| Domain | Forkhead | 4.67e-05 | 49 | 76 | 4 | PF00250 | |
| Domain | ig | 1.24e-04 | 190 | 76 | 6 | PF00047 | |
| Domain | Immunoglobulin | 1.24e-04 | 190 | 76 | 6 | IPR013151 | |
| Domain | CH | 1.42e-04 | 65 | 76 | 4 | SM00033 | |
| Domain | CH | 1.89e-04 | 70 | 76 | 4 | PF00307 | |
| Domain | - | 2.00e-04 | 71 | 76 | 4 | 1.10.418.10 | |
| Domain | CH | 2.23e-04 | 73 | 76 | 4 | PS50021 | |
| Domain | CH-domain | 2.47e-04 | 75 | 76 | 4 | IPR001715 | |
| Domain | - | 2.61e-04 | 218 | 76 | 6 | 1.10.10.10 | |
| Domain | Carbohydrate_sulfotransferase | 3.39e-04 | 7 | 76 | 2 | IPR016469 | |
| Domain | Hirudin/antistatin | 3.39e-04 | 7 | 76 | 2 | IPR011061 | |
| Domain | - | LRIG2 TGM3 CD244 FCGR3A UMODL1 FCGR3B NTRK3 ADGRF5 PLXND1 DSCAML1 | 3.43e-04 | 663 | 76 | 10 | 2.60.40.10 |
| Domain | WHTH_DNA-bd_dom | 4.56e-04 | 242 | 76 | 6 | IPR011991 | |
| Domain | Ig-like_fold | LRIG2 TGM3 CD244 FCGR3A UMODL1 FCGR3B NTRK3 ADGRF5 PLXND1 DSCAML1 | 5.61e-04 | 706 | 76 | 10 | IPR013783 |
| Domain | SM22_calponin | 8.78e-04 | 11 | 76 | 2 | IPR003096 | |
| Domain | IG | 1.61e-03 | 421 | 76 | 7 | SM00409 | |
| Domain | Ig_sub | 1.61e-03 | 421 | 76 | 7 | IPR003599 | |
| Domain | ConA-like_dom | 1.99e-03 | 219 | 76 | 5 | IPR013320 | |
| Domain | DH_1 | 2.16e-03 | 63 | 76 | 3 | PS00741 | |
| Domain | RhoGEF | 2.68e-03 | 68 | 76 | 3 | SM00325 | |
| Domain | EGF | 2.70e-03 | 235 | 76 | 5 | SM00181 | |
| Domain | RhoGEF | 2.91e-03 | 70 | 76 | 3 | PF00621 | |
| Domain | DH_2 | 2.91e-03 | 70 | 76 | 3 | PS50010 | |
| Domain | DH-domain | 3.03e-03 | 71 | 76 | 3 | IPR000219 | |
| Domain | - | 3.03e-03 | 71 | 76 | 3 | 1.20.900.10 | |
| Domain | Ig_2 | 3.28e-03 | 73 | 76 | 3 | PF13895 | |
| Domain | EGF-like_dom | 3.46e-03 | 249 | 76 | 5 | IPR000742 | |
| Domain | - | 3.58e-03 | 22 | 76 | 2 | 2.130.10.30 | |
| Domain | SEA | 3.58e-03 | 22 | 76 | 2 | PF01390 | |
| Domain | IG_LIKE | 3.81e-03 | 491 | 76 | 7 | PS50835 | |
| Domain | EGF_1 | 3.83e-03 | 255 | 76 | 5 | PS00022 | |
| Domain | SEA | 3.91e-03 | 23 | 76 | 2 | PS50024 | |
| Domain | SEA_dom | 3.91e-03 | 23 | 76 | 2 | IPR000082 | |
| Domain | RCC1/BLIP-II | 3.91e-03 | 23 | 76 | 2 | IPR009091 | |
| Domain | EGF-like_CS | 4.23e-03 | 261 | 76 | 5 | IPR013032 | |
| Domain | Ig-like_dom | 4.34e-03 | 503 | 76 | 7 | IPR007110 | |
| Domain | HECT | 5.37e-03 | 27 | 76 | 2 | PF00632 | |
| Domain | HECTc | 5.37e-03 | 27 | 76 | 2 | SM00119 | |
| Domain | HECT_dom | 5.37e-03 | 27 | 76 | 2 | IPR000569 | |
| Domain | HECT | 5.37e-03 | 27 | 76 | 2 | PS50237 | |
| Domain | Rho_GTPase_activation_prot | 5.55e-03 | 88 | 76 | 3 | IPR008936 | |
| Domain | EGF_LAM_2 | 6.60e-03 | 30 | 76 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 6.60e-03 | 30 | 76 | 2 | PS01248 | |
| Domain | - | 6.85e-03 | 95 | 76 | 3 | 2.60.120.200 | |
| Domain | Ig_I-set | 7.53e-03 | 190 | 76 | 4 | IPR013098 | |
| Domain | I-set | 7.53e-03 | 190 | 76 | 4 | PF07679 | |
| Pubmed | 1.11e-10 | 5 | 77 | 4 | 24803390 | ||
| Pubmed | Progression of the pluripotent epiblast depends upon the NMD factor UPF2. | 3.32e-10 | 6 | 77 | 4 | 36255229 | |
| Pubmed | A loss-of-function and H2B-Venus transcriptional reporter allele for Gata6 in mice. | 1.54e-09 | 8 | 77 | 4 | 26498761 | |
| Pubmed | 4.62e-09 | 10 | 77 | 4 | 23154415 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 19447925 | ||
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 1.04e-08 | 3 | 77 | 3 | 30814124 | |
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 1.04e-08 | 3 | 77 | 3 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 1.04e-08 | 3 | 77 | 3 | 17554338 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 1.04e-08 | 3 | 77 | 3 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 1.04e-08 | 3 | 77 | 3 | 18177668 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 1.04e-08 | 3 | 77 | 3 | 16259959 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 12609610 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 24227785 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 1.04e-08 | 3 | 77 | 3 | 17211451 | |
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 1.04e-08 | 3 | 77 | 3 | 23770853 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 15502159 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 1.04e-08 | 3 | 77 | 3 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 1.04e-08 | 3 | 77 | 3 | 23054952 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 1.04e-08 | 3 | 77 | 3 | 24527385 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18086680 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17204467 | ||
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 1.04e-08 | 3 | 77 | 3 | 19800316 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 23200040 | ||
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 1.04e-08 | 3 | 77 | 3 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 1.04e-08 | 3 | 77 | 3 | 23329853 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 10899756 | ||
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 1.04e-08 | 3 | 77 | 3 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 1.04e-08 | 3 | 77 | 3 | 17352742 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 1.04e-08 | 3 | 77 | 3 | 25005472 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16773043 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 1.04e-08 | 3 | 77 | 3 | 26733157 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 23071603 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 1.04e-08 | 3 | 77 | 3 | 19582141 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 21119109 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 32145514 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 19703398 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 1.04e-08 | 3 | 77 | 3 | 18097409 | |
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 1.04e-08 | 3 | 77 | 3 | 28636920 | |
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 1.04e-08 | 3 | 77 | 3 | 25753417 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20539761 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18584034 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 21969378 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20661723 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 29245050 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 22337995 | ||
| Pubmed | FoxA-dependent demethylation of DNA initiates epigenetic memory of cellular identity. | 1.04e-08 | 3 | 77 | 3 | 33636105 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18290762 | ||
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 1.04e-08 | 3 | 77 | 3 | 23333380 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 19415718 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 1672118 | ||
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 1.04e-08 | 3 | 77 | 3 | 15494369 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 25825768 | ||
| Pubmed | Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. | 1.04e-08 | 3 | 77 | 3 | 31891567 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 1.04e-08 | 3 | 77 | 3 | 14728807 | |
| Pubmed | Isolation and characterization of the murine Nanog gene promoter. | 1.04e-08 | 3 | 77 | 3 | 15916719 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 8034310 | ||
| Pubmed | Nanog retrotransposed genes with functionally conserved open reading frames. | 1.04e-08 | 3 | 77 | 3 | 16845474 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 1.04e-08 | 3 | 77 | 3 | 21194951 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 22388986 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16313224 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 9119385 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16791199 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 8187630 | ||
| Pubmed | Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6. | 1.04e-08 | 3 | 77 | 3 | 33665763 | |
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 1.04e-08 | 3 | 77 | 3 | 18024963 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 27125671 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 22028025 | ||
| Pubmed | Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. | 1.04e-08 | 3 | 77 | 3 | 28457890 | |
| Pubmed | Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. | 1.04e-08 | 3 | 77 | 3 | 18436640 | |
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 1.04e-08 | 3 | 77 | 3 | 25410303 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 33334884 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 21499299 | ||
| Pubmed | Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self-renewal. | 1.04e-08 | 3 | 77 | 3 | 33107035 | |
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 1.04e-08 | 3 | 77 | 3 | 17360937 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 35976266 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 26760119 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 1.04e-08 | 3 | 77 | 3 | 24461999 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 1.04e-08 | 3 | 77 | 3 | 30837263 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 1.04e-08 | 3 | 77 | 3 | 27939294 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 24681518 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 26549484 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18442017 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 8248124 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 21187909 | ||
| Pubmed | Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. | 1.04e-08 | 3 | 77 | 3 | 16541131 | |
| Pubmed | Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. | 1.04e-08 | 3 | 77 | 3 | 22142851 | |
| Pubmed | NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. | 1.04e-08 | 3 | 77 | 3 | 24462001 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 1.04e-08 | 3 | 77 | 3 | 22172669 | |
| Pubmed | Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. | 1.04e-08 | 3 | 77 | 3 | 23103910 | |
| Pubmed | 1.08e-08 | 12 | 77 | 4 | 27292645 | ||
| Pubmed | A Sprouty4 reporter to monitor FGF/ERK signaling activity in ESCs and mice. | 1.56e-08 | 13 | 77 | 4 | 29964027 | |
| Pubmed | Six members of the mouse forkhead gene family are developmentally regulated. | 2.98e-08 | 15 | 77 | 4 | 7689224 | |
| Pubmed | The REV7 subunit of DNA polymerase ζ is essential for primordial germ cell maintenance in the mouse. | 3.96e-08 | 16 | 77 | 4 | 23463509 | |
| Interaction | NSF interactions | 6.17e-06 | 264 | 75 | 8 | int:NSF | |
| Interaction | ZYX interactions | 3.02e-05 | 329 | 75 | 8 | int:ZYX | |
| Interaction | SYNE3 interactions | 3.91e-05 | 444 | 75 | 9 | int:SYNE3 | |
| Interaction | NACC1 interactions | 4.11e-05 | 103 | 75 | 5 | int:NACC1 | |
| Interaction | MAD2L1 interactions | 4.23e-05 | 252 | 75 | 7 | int:MAD2L1 | |
| Interaction | SAA1 interactions | 4.86e-05 | 54 | 75 | 4 | int:SAA1 | |
| GeneFamily | STT3 oligosaccharyltransferase catalytic subunits|Oligosaccharyltransferase complex subunits | 1.01e-05 | 2 | 58 | 2 | 444 | |
| GeneFamily | Forkhead boxes | 1.07e-05 | 43 | 58 | 4 | 508 | |
| GeneFamily | Immunoglobulin like domain containing | 3.81e-04 | 193 | 58 | 5 | 594 | |
| GeneFamily | Laminin subunits | 6.54e-04 | 12 | 58 | 2 | 626 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 6.54e-04 | 12 | 58 | 2 | 445 | |
| GeneFamily | Dyneins, cytoplasmic | 7.71e-04 | 13 | 58 | 2 | 538 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.24e-03 | 66 | 58 | 3 | 722 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 1.30e-03 | 67 | 58 | 3 | 519 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.77e-03 | 161 | 58 | 4 | 593 | |
| GeneFamily | Sulfotransferases, membrane bound | 6.27e-03 | 37 | 58 | 2 | 763 | |
| GeneFamily | PDZ domain containing | 1.28e-02 | 152 | 58 | 3 | 1220 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 2.88e-06 | 10 | 77 | 3 | MM741 | |
| Coexpression | MIKKELSEN_PLURIPOTENT_STATE_UP | 8.67e-06 | 14 | 77 | 3 | MM810 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 1.00e-05 | 97 | 77 | 5 | MM1016 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 2.69e-05 | 199 | 77 | 6 | M9124 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 2.77e-05 | 200 | 77 | 6 | M7500 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 3.37e-05 | 62 | 77 | 4 | MM829 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 5.30e-05 | 137 | 77 | 5 | M39241 | |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | 5.61e-05 | 227 | 77 | 6 | M18441 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 6.07e-05 | 141 | 77 | 5 | M39235 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CUL3 CD244 SACS UBR5 SYNE1 TAB2 SSH2 ARHGEF3 REV3L HERC1 BIRC6 TOR1AIP1 DYNC1H1 STT3B | 1.01e-04 | 1492 | 77 | 14 | M40023 |
| Coexpression | LIAN_LIPA_TARGETS_6M | 1.01e-04 | 82 | 77 | 4 | M4345 | |
| ToppCell | 11.5-Airway-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 5.63e-08 | 197 | 78 | 7 | e671af1b69566d97afe97f1a959a07b6f4c05620 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.83e-08 | 198 | 78 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.72e-07 | 151 | 78 | 6 | fce04bce66411c21cd5d4d41375f26f1f50f3348 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.42e-07 | 157 | 78 | 6 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-07 | 167 | 78 | 6 | bebc2493a2ee41920b21c2b774a1c5a9619315c4 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-07 | 167 | 78 | 6 | 9f2661729a2d58e17a9203a563d538c08a3dbbbc | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 5.10e-07 | 168 | 78 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-07 | 179 | 78 | 6 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-07 | 179 | 78 | 6 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 9.24e-07 | 186 | 78 | 6 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 189 | 78 | 6 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 189 | 78 | 6 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.01e-06 | 189 | 78 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PND07-Epithelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-06 | 190 | 78 | 6 | e3a2c8b637f60c963520dffe99c526809d818cab | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 1.08e-06 | 191 | 78 | 6 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.11e-06 | 192 | 78 | 6 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.11e-06 | 192 | 78 | 6 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.15e-06 | 193 | 78 | 6 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.15e-06 | 193 | 78 | 6 | c1817ad675b9f9d2d3436c8b9646edf89f0d4c82 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-06 | 193 | 78 | 6 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | E16.5-samps-Epithelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.15e-06 | 193 | 78 | 6 | 1cb5a1cffa2b4a3bfecca16b791c1992edeb237d | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.18e-06 | 194 | 78 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PND01-Epithelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-06 | 194 | 78 | 6 | d21db5e942966ed44bc78ff50130a201fc627074 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-06 | 195 | 78 | 6 | 43164511f32e4591cb5399182fbac0b911716233 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-06 | 195 | 78 | 6 | 9337111d75a487abc02969337718c30b1fe81379 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.22e-06 | 195 | 78 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.33e-06 | 198 | 78 | 6 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-06 | 198 | 78 | 6 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.33e-06 | 198 | 78 | 6 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 199 | 78 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 199 | 78 | 6 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 78 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 199 | 78 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 78 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 199 | 78 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 199 | 78 | 6 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.41e-06 | 200 | 78 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 1.41e-06 | 200 | 78 | 6 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.41e-06 | 200 | 78 | 6 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.41e-06 | 200 | 78 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Whrn_Tox2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.30e-06 | 143 | 78 | 5 | 36ce6f163fb33141c86288086c354b91853fad25 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-06 | 145 | 78 | 5 | 4f8b188a93a038afbc7a446df8467ad544f5b1cb | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 150 | 78 | 5 | b6e5e04aaf1c5265ac07581868d3159f9292a84c | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.34e-06 | 157 | 78 | 5 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-06 | 157 | 78 | 5 | eb64a4e89843895d16015c7d51805f164ed7ea5b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.43e-06 | 161 | 78 | 5 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-06 | 162 | 78 | 5 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-06 | 162 | 78 | 5 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-06 | 162 | 78 | 5 | 59147406c28b7cdf43a1815f99c15c2bd6ae8fa3 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-06 | 162 | 78 | 5 | 8e0bcc23c3086fc4b0c9dbeec13a7edaf6b83750 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-06 | 162 | 78 | 5 | 736fdcbd0f7d50fc297f13d36ab4c0dc82ad509c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 164 | 78 | 5 | dd29decc6c41a580cfdf03962827ec18d432935f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 164 | 78 | 5 | dcd3c3ee73900180451fad9b4de0efedbd375e1c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 165 | 78 | 5 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 165 | 78 | 5 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 166 | 78 | 5 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Heart-LA-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 166 | 78 | 5 | 19ec59f0a43d4eb5b4cc7bcd6480ada7f469054b | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 166 | 78 | 5 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-05 | 169 | 78 | 5 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 169 | 78 | 5 | 91cfff1ad559cc327c6bb71c98aa29f0b3642568 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 169 | 78 | 5 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 169 | 78 | 5 | 8e5e513090e86ca29fb61dfd388014774c506914 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 169 | 78 | 5 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-05 | 169 | 78 | 5 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 169 | 78 | 5 | 972618e684321060c7af2429f853a6d639e8aae8 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.23e-05 | 170 | 78 | 5 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 170 | 78 | 5 | 545c755b057871b7a22221a049a63a61713dad1d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 170 | 78 | 5 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 170 | 78 | 5 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.30e-05 | 172 | 78 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 173 | 78 | 5 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-05 | 173 | 78 | 5 | cc2e489b91562a0c6fe863e2f796f4a7d2ca27dd | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 173 | 78 | 5 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-05 | 174 | 78 | 5 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 175 | 78 | 5 | c8cfe0ac0c1ac447c626a623cc49692a0b177a1c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 175 | 78 | 5 | 61fbd8f685d3daad46449e4c0386a38886496566 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 175 | 78 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 175 | 78 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.49e-05 | 177 | 78 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-05 | 178 | 78 | 5 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-05 | 178 | 78 | 5 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.57e-05 | 179 | 78 | 5 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 179 | 78 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 180 | 78 | 5 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 180 | 78 | 5 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 182 | 78 | 5 | c1e0be27064e14043b78ae501b02d4e9542267a3 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 182 | 78 | 5 | 3c9b4869d357884ae4bcd22a9872faf83a5cfc6d | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.75e-05 | 183 | 78 | 5 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 183 | 78 | 5 | 824ecda1219fb596a01bf5cfeee29a6daa462098 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 183 | 78 | 5 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 183 | 78 | 5 | 82b84ee065fb573688d59da97a327152a1ba294c | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-05 | 184 | 78 | 5 | 24cbe9f2461ea920954e44bf3b2c2a6a5d4debfb | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.80e-05 | 184 | 78 | 5 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-05 | 184 | 78 | 5 | 98079fd048a63b51bbdf3833b6f15bf0ae99ea90 | |
| ToppCell | P28-Epithelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.80e-05 | 184 | 78 | 5 | 05811d13bd8a602095a3fcf5e55345edadc7b8bf | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-05 | 184 | 78 | 5 | 86c1551c4f7c7d0c35c14852b01b1e602fa5092a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.84e-05 | 185 | 78 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.84e-05 | 185 | 78 | 5 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-05 | 185 | 78 | 5 | 5bb513e569f3a197d55ae2ca683e202daebabeac | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 186 | 78 | 5 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| Disease | colon cancer (implicated_via_orthology) | 2.89e-06 | 11 | 78 | 3 | DOID:219 (implicated_via_orthology) | |
| Disease | Mobius Syndrome | 6.90e-06 | 2 | 78 | 2 | C0221060 | |
| Disease | Mobius II syndrome | 6.90e-06 | 2 | 78 | 2 | C0853240 | |
| Disease | level of low affinity immunoglobulin gamma Fc region receptor III-A in blood serum | 6.90e-06 | 2 | 78 | 2 | OBA_2040305 | |
| Disease | congenital disorder of glycosylation Iw (implicated_via_orthology) | 6.90e-06 | 2 | 78 | 2 | DOID:0080572 (implicated_via_orthology) | |
| Disease | Lupus Vasculitis, Central Nervous System | 2.07e-05 | 3 | 78 | 2 | C0752332 | |
| Disease | Lupus Meningoencephalitis | 2.07e-05 | 3 | 78 | 2 | C0752334 | |
| Disease | Neuropsychiatric Systemic Lupus Erythematosus | 2.07e-05 | 3 | 78 | 2 | C0752335 | |
| Disease | KDEL motif-containing protein 2 measurement | 4.12e-05 | 4 | 78 | 2 | EFO_0801740 | |
| Disease | Hyperinsulinism | 5.55e-05 | 28 | 78 | 3 | C0020459 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 8.75e-05 | 169 | 78 | 5 | DOID:3908 (is_marker_for) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 1.44e-04 | 7 | 78 | 2 | EFO_0008211 | |
| Disease | platelet component distribution width | 1.69e-04 | 755 | 78 | 9 | EFO_0007984 | |
| Disease | plexin-B2 measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0021867 | |
| Disease | cup-to-disc ratio measurement, optic cup area measurement, optic disc area measurement | 3.06e-04 | 10 | 78 | 2 | EFO_0006937, EFO_0006939, EFO_0006940 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 4.94e-04 | 58 | 78 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 6.15e-04 | 14 | 78 | 2 | EFO_0008212 | |
| Disease | precuneus cortex volume measurement | 6.15e-04 | 14 | 78 | 2 | EFO_0010326 | |
| Disease | hemorrhoid | 6.34e-04 | 147 | 78 | 4 | EFO_0009552 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.18e-04 | 152 | 78 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 9.14e-04 | 17 | 78 | 2 | EFO_0021969 | |
| Disease | Intellectual Disability | 1.20e-03 | 447 | 78 | 6 | C3714756 | |
| Disease | waist-hip ratio | NRXN3 SPSB1 PRIM1 LAMA4 ADGRF5 PLXND1 FOXA3 BIRC6 MAML3 ARHGAP21 | 1.43e-03 | 1226 | 78 | 10 | EFO_0004343 |
| Disease | nucleus accumbens volume | 1.54e-03 | 22 | 78 | 2 | EFO_0006931 | |
| Disease | arginine measurement | 1.68e-03 | 23 | 78 | 2 | EFO_0020990 | |
| Disease | nose morphology measurement | 1.82e-03 | 329 | 78 | 5 | EFO_0007843 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 1.99e-03 | 25 | 78 | 2 | EFO_0021970 | |
| Disease | Endogenous Hyperinsulinism | 2.15e-03 | 26 | 78 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 2.15e-03 | 26 | 78 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 2.15e-03 | 26 | 78 | 2 | C1257965 | |
| Disease | optic disc size measurement | 2.16e-03 | 205 | 78 | 4 | EFO_0004832 | |
| Disease | red blood cell density measurement | 2.26e-03 | 880 | 78 | 8 | EFO_0007978 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.46e-03 | 101 | 78 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | mean corpuscular hemoglobin concentration | 2.52e-03 | 1105 | 78 | 9 | EFO_0004528 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSFQVSWRLNSTQNH | 326 | Q5DID0 | |
| NYQNLNQSVAHDWTS | 776 | O15013 | |
| THSLQANDTFNKQQW | 426 | Q9NR81 | |
| WSFINNNLHTQSLNR | 2201 | Q9NR09 | |
| KQQQHWGRTDSNFTS | 461 | Q86XM0 | |
| NGTSIQWKNHDQNNH | 401 | P25101 | |
| QWKNHDQNNHNTDRS | 406 | P25101 | |
| HAAQWTFSAQNASLR | 251 | P34810 | |
| NQNTQVTEAWNKVAH | 161 | Q9UQ80 | |
| QNHWTRSTQTTRESQ | 196 | Q99102 | |
| QQQQQHSNQTSNWSP | 506 | Q96JK9 | |
| TGLQSINTHQTNLNW | 246 | Q16288 | |
| INTHQTNLNWTNVHA | 251 | Q16288 | |
| SSRLSSQHRQWAAQQ | 3376 | Q15751 | |
| TLQQDCTNSSQQHFW | 576 | Q9Y4D7 | |
| DNQWHNVVITRDNSN | 951 | Q9Y4C0 | |
| WSNQTQNIQSWSNHS | 206 | Q9H9S0 | |
| QNIQSWSNHSWNTQT | 211 | Q9H9S0 | |
| QTSDSQHEWSQLLSN | 711 | Q6ZMV9 | |
| HNDNSWIRQRSASVN | 1481 | Q8WWI1 | |
| NNEDISRIITNNHWS | 836 | Q8NEV8 | |
| NNHWSSALTDTQNAQ | 846 | Q8NEV8 | |
| SAGNSQWHLLQREQS | 411 | Q9NZ52 | |
| DQWASNASVSHQDQQ | 1021 | Q13219 | |
| DGSSNNSERWQHQIK | 36 | Q9H772 | |
| NQSADHRAAWDSQQA | 361 | Q9Y6M4 | |
| SAHWQQPDSSQQIQA | 201 | Q8WVV4 | |
| NWINQTEAQTGQRSH | 1081 | Q86VI3 | |
| QQSFQKSHNSLQRWE | 256 | P49642 | |
| QQRWQNSIRHSLSFN | 211 | P55317 | |
| INSTHARLNLQGWNN | 1491 | Q8TD84 | |
| TQHINNWLTNLDASN | 306 | Q9P2H0 | |
| NWLTNLDASNTQNVT | 311 | Q9P2H0 | |
| FLQTLNQAWNDHQTA | 101 | Q13618 | |
| QTFASNWRKINAHNN | 56 | P09668 | |
| DSTWQSSLDTNNNSH | 266 | Q5U623 | |
| HLQNQSNNSNWNLRT | 166 | O95243 | |
| NSTQWFHNESLISSQ | 56 | O75015 | |
| QGWQNSIRHNLSLND | 91 | Q12952 | |
| QNLFTTWSHHLQQAN | 3526 | Q14204 | |
| NHNNINQWTASIVEQ | 36 | P51808 | |
| QWSQRHQDVFSSAQR | 231 | Q13753 | |
| NNSTRLWNSQSSIDQ | 506 | Q902F9 | |
| NISQENLSHWNLDSE | 16 | Q8IXS0 | |
| NSTQWFHNESLISSQ | 56 | P08637 | |
| SERWTQNEHLTQNEQ | 396 | Q92681 | |
| WNQEATSHKSERQQQ | 4401 | Q9NZJ4 | |
| SWESHTLNLTQDCQN | 206 | Q9BZW8 | |
| SQREAQAAWETQHQL | 391 | Q8N137 | |
| HRSQAQSSVSLQQGW | 1261 | Q9BZA8 | |
| SSQLAANHWNQQQAE | 1191 | Q9HAU5 | |
| ANNLTNWSQNLQHFD | 756 | Q16363 | |
| DTSQASAQHQLWKQS | 451 | A6ND36 | |
| QRWQNSIRHSLSFND | 201 | Q9Y261 | |
| ANQRAWQNSIRHNLS | 71 | A0A1W2PRP0 | |
| NESSLRSSNHTLIWN | 191 | Q86VV8 | |
| QNLNRHWSLISSQTT | 7431 | Q8NF91 | |
| TRQTQQHSGWVSQFN | 226 | Q9NYJ8 | |
| RHLPNSNNNSSSWLN | 56 | A1L390 | |
| WSNQTQNIQSWSNHS | 206 | Q6NSW7 | |
| QNIQSWSNHSWNTQT | 211 | Q6NSW7 | |
| ENQQRWQNSIRHSLS | 156 | P55318 | |
| SSWQGENQSQRSIHV | 406 | Q9NQW5 | |
| LVDNNTWNNTHISRV | 541 | P46977 | |
| HSQESNSLQQQSWYG | 511 | Q9NRP7 | |
| VQSINWQTAFNRQAH | 6 | Q08188 | |
| QQWTNQSSQLLHSVE | 816 | Q8IZF2 | |
| FHTSSRNARNVSQAW | 341 | Q9GZS9 | |
| TSSRNALNVSQAWRH | 321 | Q9GZX3 | |
| NESTQNWHQLENIGN | 76 | P51911 | |
| RAQDADSVWQQQQAH | 521 | Q70EL4 | |
| DSVWQQQQAHQQHSC | 526 | Q70EL4 | |
| THISNNHGNNFWNSS | 186 | Q86XN6 | |
| NHGNNFWNSSLLTQK | 191 | Q86XN6 | |
| WQSSQSQNFTAHDKQ | 261 | Q5JTV8 | |
| STIDSNENRRHNQWK | 1731 | O60673 | |
| SHINSDQSSVNEWNA | 211 | Q76I76 | |
| QLLHSWNNNDRSLNV | 51 | Q96BD6 | |
| NRTTLVDNNTWNNSH | 616 | Q8TCJ2 | |
| QTQNIQSWSNHSWNT | 136 | Q8N7R0 | |
| NQSSNLIEQSNSYWR | 551 | Q9H8G1 | |
| NSWENNTLSHFSSNV | 321 | Q86XD8 | |
| HQNSLLNQQTWVRTD | 656 | Q5T5U3 | |
| NGQQWLQSTSGSQRH | 481 | Q9H808 | |
| WAVRNTQHQRAASTA | 1716 | O95071 | |
| QWLVDNNFQHSVNVS | 456 | O94898 | |
| QNRAVQEWSVQQVSH | 981 | Q9ULJ8 |